FIELD: medicine, pharmaceutics.
SUBSTANCE: what is presented is an agent for poly(ADP-riboso)polymerase inhibition. The agent represents 7-methylguanine(2-amino-7-methyl-1H-purin-6(7H)-one)- a purine derivative of formula (I) The agent has shown the efficacy higher than that in 7-methyl-xanthine and is non-toxic for the human body.
EFFECT: agent can be used in treating conditions caused by necrotic cell death: stroke, myocardial ischemia, diabetes and complications thereof, shock, neurotrauma, arthritis, colitis, allergic encephalomyelitis and other inflammations.
1 dwg, 2 ex
Title | Year | Author | Number |
---|---|---|---|
MEDICATION FOR INHIBITING HUMAN ENZYME POLY(ADP-RIBOSE)POLYMERASE-1 | 2009 |
|
RU2411948C1 |
AGENT FOR INHIBITING HUMAN POLY(ADP-RIBOSE)POLYMERASE-1 ENZYME | 2012 |
|
RU2500675C1 |
INHIBITORS OF HUMAN POLY(ADP-RIBOSO)POLYMERASE-1 BASED ON URACYL DERIVATIVES | 2012 |
|
RU2527457C2 |
THERAPEUTIC COMBINATIONS CONTAINING INHIBITOR OF POLY(ADP-RIBOSE)POLYMERASE | 2005 |
|
RU2361592C2 |
USE OF A GUANINE DERIVATIVE TO INHIBIT POLY(ADP-RIBOSE)POLYMERASE | 2022 |
|
RU2783240C1 |
POLY(ADP-RIBOSE)POLYMERASE INHIBITOR PRODUCTION METHOD | 2005 |
|
RU2344138C2 |
TRICYCLIC PARP INHIBITORS | 2004 |
|
RU2404183C2 |
PARP-INHIBITING COMPOUNDS AND COMPOSITIONS, AND METHODS FOR USING THEM | 2008 |
|
RU2485122C2 |
POLYMORPHOUS AND AMORPHOUS FORMS OF 8-FLUORO-2-{4-[(METHYLAMINO)METHYL]PHENYL}-1,3,4,5-TETRAHYDRO-6H-AZEPINE[5,4,3-CD]INDOL-6-ON PHOSPHATE | 2005 |
|
RU2355691C2 |
AGENT FOR INHIBITING THE HUMAN TYROSYL-DNA-PHOSPHODIESTERASE 1 ENZYME BASED ON PENTAFURANOSYL NUCLEOSIDE DERIVATIVES | 2019 |
|
RU2748103C1 |
Authors
Dates
2014-07-20—Published
2012-09-19—Filed